Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis
Although more evidence is needed, continuation of semaglutide after dialysis initiation appears safe and warrants efficacy testing regarding reduction in MACE and death.
Authors
- Ildiko Lingvay (ORCID: https://orcid.org/0000-0001-7006-7401)
- Margit Riis Andersen
- Johannes F.E. Mann (ORCID: https://orcid.org/0000-0002-3154-5332)
- Anna Menacher
- Klara R. Klein (ORCID: https://orcid.org/0000-0002-5894-9054)
- Katherine R. Tuttle
- Manuel Mayrdorfer
- Kajsa Kvist
- John B. Buse
Institutions
- University of North Carolina at Chapel Hill (US)
- Novo Nordisk (Denmark) (DK)
- University of Washington (US)
- Universitätsklinikum Erlangen (DE)
- Kidney Centre (PK)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-03-27
- DOI
- https://doi.org/10.2337/dc26-0112
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00